logo
Plus   Neg
Share
Email

EARNINGS SUMMARY: Details of RXi Pharmaceuticals Corp. Q3 Earnings Report

Below are the earnings highlights for RXi Pharmaceuticals Corp. (RXII):

-Earnings: -$1.49 million in Q3 vs. -$2.48 million in the same period last year.
-EPS: -$0.34 in Q3 vs. -$1.05 in the same period last year.

For comments and feedback contact: editorial@rttnews.com

Follow RTT